BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25687854)

  • 1. Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer.
    Hingorani M; Dixit S; Johnson M; Plested V; Alty K; Colley P; Beavis AW; Roy R; Maraveyas A
    Cancer Res Treat; 2015 Oct; 47(4):706-17. PubMed ID: 25687854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.
    Mizrak Kaya D; Wang X; Harada K; Blum Murphy MA; Das P; Minsky BD; Estrella JS; Lin Q; Amlashi FG; Lee JH; Weston B; Bhutani MS; Matamoros A; Sagebiel T; Wu CC; Rogers JE; Thomas I; Maru DM; Skinner HD; Badgwell BD; Hofstetter WL; Ajani JA
    Oncology; 2017; 93(4):243-248. PubMed ID: 28683449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention of platinum sensitivity till late stages of tumour progression may imply improved prognosis of oesophageal and gastric cancers.
    Hingorani M; Dixit S; Roy R; Maraveyas A
    Oncol Res Treat; 2015; 38(1-2):28-34. PubMed ID: 25634795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Overall Survival with Aggressive Primary Tumor Radiotherapy for Patients with Metastatic Esophageal Cancer.
    Guttmann DM; Mitra N; Bekelman J; Metz JM; Plastaras J; Feng W; Swisher-McClure S
    J Thorac Oncol; 2017 Jul; 12(7):1131-1142. PubMed ID: 28461255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
    Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
    World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
    Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reliable risk score for stage IV esophagogastric cancer.
    Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
    Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study.
    Dijksterhuis WPM; Verhoeven RHA; Slingerland M; Haj Mohammad N; de Vos-Geelen J; Beerepoot LV; van Voorthuizen T; Creemers GJ; van Oijen MGH; van Laarhoven HWM
    Int J Cancer; 2020 Apr; 146(7):1889-1901. PubMed ID: 31340065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
    Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
    Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin and paclitaxel as first-line treatment of unresectable or metastatic esophageal or gastric cancer.
    Prithviraj GK; Baksh K; Fulp W; Meredith K; Hoffe S; Shridhar R; Almhanna K
    Dis Esophagus; 2015; 28(8):782-7. PubMed ID: 25155802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.
    Lee SS; Lee JL; Ryu MH; Chang HM; Kim TW; Kang HJ; Kim WK; Lee JS; Kang YK
    Jpn J Clin Oncol; 2007 Jan; 37(1):30-7. PubMed ID: 17272321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions.
    Opstelten JL; de Wijkerslooth LR; Leenders M; Bac DJ; Brink MA; Loffeld BC; Meijnen-Bult MJ; Minderhoud IM; Verhagen MA; van Oijen MG; Siersema PD
    Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26919349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefit of palliative radiation therapy in advanced gastric cancer.
    Kim MM; Rana V; Janjan NA; Das P; Phan AT; Delclos ME; Mansfield PF; Ajani JA; Crane CH; Krishnan S
    Acta Oncol; 2008; 47(3):421-7. PubMed ID: 17899453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is chemotherapy in elderly patients with metastatic or recurrent gastric cancer as tolerable and effective as in younger patients?
    Kim ST; Park KH; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):194-200. PubMed ID: 22524579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting outcome for advanced gastroesophageal cancer in elderly patients receiving palliative chemotherapy.
    Lord SR; Hall PS; McShane P; Brown J; Seymour MT
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):107-13. PubMed ID: 20053542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of multimodality therapy for stage IVB esophageal cancer with distant organ metastasis (M1-Org).
    Tanaka T; Fujita H; Matono S; Nagano T; Nishimura K; Murata K; Shirouzu K; Suzuki G; Hayabuchi N; Yamana H
    Dis Esophagus; 2010 Nov; 23(8):646-51. PubMed ID: 20545979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
    Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G
    Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.